ECG Devices Market Size, Share, and Growth Forecast for 2025 - 2032

ECG Devices Market Size and Trends

The global ECG devices market size is anticipated to reach a value of US$ 6,840.8 Mn in 2025 and is set to witness a CAGR of 7.4% from 2025 to 2032. The market will likely attain a value of US$ 11,303.6 Mn in 2032.

Assume that a passenger suddenly collapses as you board a long-haul flight. As soon as a flight attendant arrives, a portable device records the passenger’s heartbeat and detects a possible cardiac event. This situation is not from a medical drama- it is real, and it is made possible by innovative electrocardiogram (EEG) technology.

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) continue to be the most prominent cause of mortality worldwide, taking the lives of around 20.5 Mn individuals each year. The need for early and real-time diagnostics has never been higher due to the sharp increase in heart disease cases. This is where ECG devices, whether in ambulances, remote villages, or even on a person's wrist via smartwatches, have transformed healthcare.

Key Highlights of the ECG Devices Industry

• By end user, hospitals are anticipated to generate 52.7% share in 2025 backed by the urgent need for precise and prompt heart health diagnostics.
• Based on product, ECG resting systems are projected to hold 55.4% share in 2025 due to their ability to rapidly deliver high-precision, multi-lead cardiac assessments.
• The U.S. is predicted to hold 29.3% share in 2025 spurred by implementation of several investment programs for the prevention of heart disease.
• Developments in wearable technology are set to lead to the emergence of innovative ECG devices for long-term tracking of heart rhythms to detect silent attacks.
• Need for real-time ECG monitoring is becoming significant in the space industry as it is important to assess astronaut health to prevent heart attacks.

Historical Growth and Course Ahead

Significance of Remote Cardiac Monitoring Spurred in the Historical Period as Regulatory Approvals Expanded

As per Persistence Market Research, in the historical period from 2019 to 2024, the global ECG devices industry witnessed a decent CAGR of around 6.4%. Adoption of wearable ECG monitors was a significant trend between 2019 and 2020, especially by tech companies venturing into the healthcare sector. For example, Apple's ECG-enabled Apple Watch was approved by the FDA in 2018 and collected more than 100 Mn ECG readings worldwide by 2020.

The market was significantly impacted by the COVID-19 pandemic. Hospitals around the world were overloaded with COVID-19 cases by mid-2020, and non-urgent cardiac procedures were postponed. However, the pandemic made the necessity of remote cardiac monitoring significant, which resulted in a record-breaking spike in demand for portable ECG devices. In 2021, for example, the U.S. FDA granted emergency use authorization for several portable ECG devices, including AliveCor’s KardiaMobile 6L.

Forecast Period to See ECG Device Innovations in Space Industry to Monitor Astronaut Health in Real Time

From 2025 to 2032, the ECG devices industry is likely to showcase a CAGR of 7.4%. The forecast period is anticipated to witness innovations in these devices mainly in the space industry. NASA, for instance, has long depended on ECG technology to assess the heart health of astronauts during space missions. Real-time ECG monitoring is significant for minimizing heart-related issues, enhancing astronaut health, and guaranteeing mission success as extended exposure to space environments can have a substantial impact on cardiac function.

NASA tracks the cardiac activity of astronauts while aboard the International Space Station (ISS) using wearable ECG devices. Heart data can be transmitted in real time to flight surgeons on Earth due to the agency's integration of biomedical monitoring suits with ECG sensors. The BioMonitor system, a wireless, lightweight ECG vest designed for ongoing cardiovascular monitoring in space, is one such example. Similar innovations in ECG devices for accurately monitoring the heart health of astronauts are projected to boost growth through 2032.

Market Dynamics

Growth Driver

Wearable Technology Providers to Integrate ECG Features for Early Heart Disease Detection

Rising prevalence of silent heart attacks, i.e., cardiac episodes that exhibit no instant symptoms but cause long-lasting damage, is projected to create high demand for ECG devices. As per a study published in the journal named Circulation, around 45% of all heart attacks are silent and often go undiagnosed.

Wearable technology providers are hence increasingly incorporating ECG devices to address this issue. Doing so can help detect even slight variations in heart rhythms that might otherwise go unnoticed. For example, an early sign of heart failure, left ventricular dysfunction, was effectively detected by an Apple Watch ECG feature in 2022, according to a Mayo Clinic study. More research and development activities in this field are anticipated to push the market.

Market Restraining Factor

Rising Data Privacy Concerns May Affect Adoption of Cloud-connected ECG Devices

Despite the rising prevalence of cardiovascular diseases, demand for ECG devices has witnessed specific roadblocks. The industry has been facing rising scrutiny from regulatory bodies, which has caused delays in product approvals and market entry.

Strict safety and accuracy requirements set by agencies like the European Medicines Agency (EMA), China's National Medical Products Administration (NMPA), and the U.S. Food and Drug Administration (FDA) must be met by conventional ECG devices. Data privacy norms like HIPAA and GDPR, especially for cloud-connected devices, have also created hindrances, declining adoption in healthcare facilities handling confidential patient information. For instance,

• In 2022, iRhythm Technologies, a significant company in the field of ECG monitoring, experienced a decline in stock prices of more than 30% when the U.S. FDA rejected its next-generation Zio monitor on regulatory grounds.

Such challenges prove that it is becoming increasingly difficult for key players to launch new ECG devices in the global market. It may create hindrances for market growth to a certain extent.

Key Market Opportunity

Surging Focus on Athlete Cardiac Health to Spur Development of New ECG Devices

Use of ECG devices in sports medicine and athletic performance is anticipated to create new opportunities for market players. Individual athletes, sports organizations, and professional teams are gradually realizing the significance of cardiac health monitoring in high-intensity training and competition.

Athletes, especially those with undiagnosed cardiac conditions, are more likely to experience exercise-induced cardiac events. According to a report published in JAMA Cardiology, every year, in the U.S., sudden cardiac death accounts for around 75% of all athlete-related deaths. As a result, ECG screening is now required as part of pre-participation medical evaluations by various sports governing bodies.

For instance, professional football players must get an ECG examination before big tournaments as part of FIFA's Pre-competition Medical Assessment (PCMA) to identify any possible cardiac issues. Owing to the aforementioned factors, medical device companies are anticipated to invest in research activities to come up with new ECG devices for the sports industry.

ECG Devices Market Insights

Product Insights

ECG Resting Systems Gain Impetus as Global Norms Encourage Regular Cardiac Screening

In the global ECG devices industry, the ECG resting system segment is predicted to account for a share of 55.4% in 2025. These systems are likely to gain momentum backed by the urgent need for early disease detection, regulatory mandates, and surging CVD prevalence. Resting ECG systems are essential for hospitals, clinics, and diagnostic centers worldwide as these can quickly deliver high-precision, multi-lead cardiac assessments, unlike Holter monitors.

Demand is further surging as governments and healthcare organizations globally are mandating regular ECG tests for high-risk populations. The European Society of Cardiology (ESC) revised their recommendations in 2023 to encourage yearly resting ECG tests for those over 50, mainly living with diabetes, hypertension, or a family history of heart disease.

ECG stress testing systems, on the other hand, are projected to exhibit considerable growth in the forecast period. These systems offer in-depth insights into heart function under physical exertion, ischemia, and exercise-induced arrhythmias. Hence, these are considered important for both performance assessment of athletes and clinical diagnostics.

End User Insights

Emergency and Post-operative Needs to Propel Adoption of ECG Devices in Hospitals

By end user, the hospitals segment is anticipated to hold an ECG devices market share of 52.7% in 2025. To guarantee prompt and precise heart health diagnostics, hospitals depend on novel ECG devices, right from emergency cardiac monitoring to pre-operative evaluations and post-operative rehabilitation. Every day, hospitals treat an enormous number of cardiac patients, necessitating constant ECG monitoring for quick disease detection. For instance,

• The American Heart Association (AHA) estimates that 805,000 Americans suffer a heart attack annually, with about 20% of those being silent attacks that often go undiagnosed until an ECG test is conducted.

Ambulatory surgical centers, on the other hand, are set to showcase a steady rise in the adoption of ECG devices through 2032. Innovative ECG devices are being used to improve patient safety, identify underlying heart issues, and comply with preoperative evaluation regulations.

Regional Insights and Trends

North America ECG Devices Market

Remote Cardiac Care in Canada to Advance as At-home ECG Monitoring Gains Traction in Northern Regions

In North America, the U.S. ECG devices market is projected to account for a share of 29.3% in 2025. Demand is being driven by the U.S. government's significant investments in the prevention of cardiac disease.

The Million Hearts® Program is one of the various programs that the American Heart Association (AHA) and the National Institutes of Health (NIH) have started with the aim of preventing 1 Mn heart attacks and strokes by 2027. Hospitals are extending ECG screening programs as part of this endeavor, especially for high-risk populations, including patients with diabetes and hypertension.

Clinics and healthcare providers can now adopt innovative ECG devices in the U.S. without facing financial issues due to enhanced Medicare reimbursement standards for ECG procedures. Hence, healthcare facilities are increasingly using stress ECG machines, Holter monitors, and resting ECG systems.

In Canada, patients are set to use at-home ECG devices and share real-time data with cardiologists for analysis during virtual cardiac consultations offered by telemedicine platforms such as Maple, Dialogue, and TELUS Health. In remote areas like Northern Canada, where access to specialized cardiac care is scarce, this has already proven very helpful.

Middle East and Africa ECG Devices Market

National Health Strategy 2050 to Propel ECG Device Use in UAE’s Remote Monitoring and Primary Care Centers

In the Middle East and Africa, the United Arab Emirates (UAE) has become a leading hub for automated ECG diagnostics. Early cardiac detection is becoming essential as heart disease causes 30% of all fatalities in the UAE, according to the Dubai Health Authority (DHA).

The UAE government’s National Health Strategy 2050, for example, focuses on improving cardiac care by using smart ECG systems. It is resulting in rising investments in ECG devices, especially in remote monitoring services and primary healthcare centers.

As heart disease is the main cause of early deaths in Qatar, the government has made cardiac screening programs mandatory for high-risk individuals. This has increased the use of Holter monitors and resting ECG. One of the most significant healthcare providers in the country, Hamad Medical Corporation, has increased the use of ECG devices by broadening its ECG-based screening programs for patients with diabetes and hypertension.

Asia Pacific ECG Devices Market

China’s Healthcare Digitization Spurs Growth as Alibaba Health and Tencent Invest in Cloud-based Monitoring

In Asia Pacific, China is projected to rise steadily in the foreseeable future with rapid digitization in the healthcare sector. Companies like Alibaba Health and Tencent are constantly investing in the development of cloud-based ECG monitoring platforms. More than 100 hospitals have already used Tencent's AI-assisted ECG technology, which greatly enhanced the detection of ischemic heart disease and arrhythmias.

As per the Japanese Circulation Society, in Japan, it is estimated that more than 10 Mn individuals suffer from arrhythmias. It is projected to lead to a rising adoption of wearable ECG patches and Holter ECG monitors for long-term tracking of heart rhythms. Wireless ECG patches that connect to smartphones for real-time cardiac monitoring are among the first miniaturized ECG devices developed by companies like Omron Healthcare and Fukuda Denshi.

ECG Devices Market Competitive Landscape

The ECG devices market has been showcasing constant developments in recent years with a rising focus of companies on remote patient monitoring and technological development. They are also actively joining hands with other companies to launch multi-functional devices that blend ECG capabilities with novel diagnostic systems to enhance early disease detection.

A few other key players are focusing on regional expansions to strengthen their positions. They are further integrating cloud-based platforms to enhance the efficiency of ECG devices, making these more accessible in underserved areas and home settings.

Key Industry Developments

• In December 2024, DocGo Inc. broadened its partnership with SHL Telemedicine to integrate the SmartHeart® portable 12-lead ECG device across DocGo mobile health care units. Initially launched in New York, this extended partnership will now provide cutting-edge cardiovascular diagnostics to patients' homes and underserved areas in other markets.
• In September 2024, OMRON Healthcare Korea introduced OMRON Complete, its new home-use medical device that can simultaneously measure ECG and blood pressure. The device helps in preventing the risk of complications like heart failure and stroke among individuals at risk for cardiovascular diseases.
• In May 2024, OMRON Healthcare India collaborated with AliveCor India to provide AI-based handheld ECG technology. This collaboration marked an important milestone in the former’s ‘Going for Zero’ vision to improve cardiovascular health awareness.  

ECG Devices Market Report Scope

ECG Devices Market Segmentation

By Product

• ECG Resting System
• ECG Holter Monitoring System
• ECG Stress Testing System
• Cardiopulmonary Stress Testing System

By End User

• Hospital
• Diagnostic Centers
• Clinics
• Ambulatory Surgical Centers

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

To know more about delivery timeline for this report Contact Sales